<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Marshall, Jessica</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Draft guidelines for nanomedicine unveiled</style></title><secondary-title><style face="normal" font="default" size="100%">Nature</style></secondary-title><short-title><style face="normal" font="default" size="100%">Nature</style></short-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Medical Use</style></keyword><keyword><style  face="normal" font="default" size="100%">Nanotechnology Policy and Development -  United States</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">9/2011</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.nature.com/news/2011/110928/full/news.2011.562.html</style></url></web-urls></urls><abstract><style face="normal" font="default" size="100%">A project at the University of Minnesota, Minneapolis, funded by the U.S. National Institutes of Health, have developed a draft set of recommendations for how to ensure the effective oversight of the emerging field of nanomedicine. Their recommendations include recommending the creation of an interagency working group to look at how agencies are evaluating the risks and hazards of nanoscale technologies, and an advisory committee that includes expert members of the public similar to those that already exist for research on human subjects.</style></abstract></record></records></xml>